Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Modulation of pancreatic cancer chemoresistance by inhibition of TAK1.
Melisi D, Xia Q, Paradiso G, Ling J, Moccia T, Carbone C, Budillon A, Abbruzzese JL, Chiao PJ. Melisi D, et al. Among authors: moccia t. J Natl Cancer Inst. 2011 Aug 3;103(15):1190-204. doi: 10.1093/jnci/djr243. Epub 2011 Jul 8. J Natl Cancer Inst. 2011. PMID: 21743023 Free PMC article.
Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.
Ciardiello C, Leone A, Lanuti P, Roca MS, Moccia T, Minciacchi VR, Minopoli M, Gigantino V, De Cecio R, Rippa M, Petti L, Capone F, Vitagliano C, Milone MR, Pucci B, Lombardi R, Iannelli F, Di Gennaro E, Bruzzese F, Marchisio M, Carriero MV, Di Vizio D, Budillon A. Ciardiello C, et al. Among authors: moccia t. J Exp Clin Cancer Res. 2019 Jul 18;38(1):317. doi: 10.1186/s13046-019-1317-6. J Exp Clin Cancer Res. 2019. PMID: 31319863 Free PMC article.
Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.
Iannelli F, Roca MS, Lombardi R, Ciardiello C, Grumetti L, De Rienzo S, Moccia T, Vitagliano C, Sorice A, Costantini S, Milone MR, Pucci B, Leone A, Di Gennaro E, Mancini R, Ciliberto G, Bruzzese F, Budillon A. Iannelli F, et al. Among authors: moccia t. J Exp Clin Cancer Res. 2020 Oct 8;39(1):213. doi: 10.1186/s13046-020-01723-7. J Exp Clin Cancer Res. 2020. PMID: 33032653 Free PMC article.
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
Roca MS, Moccia T, Iannelli F, Testa C, Vitagliano C, Minopoli M, Camerlingo R, De Riso G, De Cecio R, Bruzzese F, Conte M, Altucci L, Di Gennaro E, Avallone A, Leone A, Budillon A. Roca MS, et al. Among authors: moccia t. J Exp Clin Cancer Res. 2022 Mar 3;41(1):83. doi: 10.1186/s13046-022-02295-4. J Exp Clin Cancer Res. 2022. PMID: 35241126 Free PMC article.
Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression.
Ciardiello C, Roca MS, Noto A, Bruzzese F, Moccia T, Vitagliano C, Di Gennaro E, Ciliberto G, Roscilli G, Aurisicchio L, Marra E, Mancini R, Budillon A, Leone A. Ciardiello C, et al. Among authors: moccia t. Oncotarget. 2016 Apr 12;7(15):19559-74. doi: 10.18632/oncotarget.7195. Oncotarget. 2016. PMID: 26862736 Free PMC article.
Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
Roca MS, Moccia T, Iannelli F, Testa C, Vitagliano C, Minopoli M, Camerlingo R, De Riso G, De Cecio R, Bruzzese F, Conte M, Altucci L, Di Gennaro E, Avallone A, Leone A, Budillon A. Roca MS, et al. Among authors: moccia t. J Exp Clin Cancer Res. 2022 Apr 11;41(1):138. doi: 10.1186/s13046-022-02324-2. J Exp Clin Cancer Res. 2022. PMID: 35410264 Free PMC article. No abstract available.
Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase.
Di Gennaro E, Piro G, Chianese MI, Franco R, Di Cintio A, Moccia T, Luciano A, de Ruggiero I, Bruzzese F, Avallone A, Arra C, Budillon A. Di Gennaro E, et al. Among authors: moccia t. Br J Cancer. 2010 Nov 23;103(11):1680-91. doi: 10.1038/sj.bjc.6605969. Epub 2010 Nov 2. Br J Cancer. 2010. PMID: 21045833 Free PMC article.
Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance.
Iannelli F, Zotti AI, Roca MS, Grumetti L, Lombardi R, Moccia T, Vitagliano C, Milone MR, Ciardiello C, Bruzzese F, Leone A, Cavalcanti E, De Cecio R, Iachetta G, Valiante S, Ionna F, Caponigro F, Di Gennaro E, Budillon A. Iannelli F, et al. Among authors: moccia t. Front Cell Dev Biol. 2020 Aug 17;8:732. doi: 10.3389/fcell.2020.00732. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33015030 Free PMC article.
18 results